↓ Skip to main content

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

Overview of attention for article published in Cardiovascular Diabetology, March 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
146 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
Published in
Cardiovascular Diabetology, March 2019
DOI 10.1186/s12933-019-0839-8
Pubmed ID
Authors

Agnes Bosch, Christian Ott, Susanne Jung, Kristina Striepe, Marina V. Karg, Dennis Kannenkeril, Thomas Dienemann, Roland E. Schmieder

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 146 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 16%
Student > Master 22 15%
Researcher 12 8%
Student > Ph. D. Student 11 8%
Student > Doctoral Student 5 3%
Other 16 11%
Unknown 57 39%
Readers by discipline Count As %
Medicine and Dentistry 43 29%
Nursing and Health Professions 13 9%
Biochemistry, Genetics and Molecular Biology 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Unspecified 3 2%
Other 9 6%
Unknown 67 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2020.
All research outputs
#6,908,939
of 23,138,859 outputs
Outputs from Cardiovascular Diabetology
#446
of 1,409 outputs
Outputs of similar age
#128,142
of 351,128 outputs
Outputs of similar age from Cardiovascular Diabetology
#13
of 28 outputs
Altmetric has tracked 23,138,859 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,409 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,128 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.